Other / Other / MRI

Oral cavity Squamous cell carcinoma

Oral cavity squamous cell carcinoma is the most common malignancy in the oral region. Imaging is performed to assess primary tumor extent, bone invasion, and cervical lymph node metastases for staging and treatment planning.
Look For First
  • Irregular mucosal thickening or mass at high-risk sites (anterior 2/3 tongue, floor of mouth, lower lip) with heterogeneous enhancement
  • Loss of normal fat planes between tumor and adjacent mandible or maxilla indicating potential bony invasion
  • Cervical lymphadenopathy with short-axis diameter >1 cm or central necrosis suggesting nodal metastasis
Key Image Findings
  • Primary tumor typically presents as irregular mucosal thickening or exophytic mass with heterogeneous intermediate T2 signal intensity and heterogeneous post-gadolinium enhancement on MRI.
  • Over 75% of oral cavity squamous cell carcinomas arise in the lower lip, oral tongue, and floor of mouth, making these high-risk locations that must be scrutinized carefully.
  • Tumor size determines T-staging: T1 ≤2 cm, T2 2-4 cm, T3 >4 cm, and T4 tumors show invasion into adjacent structures such as mandible, maxilla, or soft tissues of neck on MRI or CT.
  • Bone invasion appears as cortical destruction, marrow signal abnormality, or loss of normal cortical/medullary definition on MRI; cortical erosion or medullary lucency on CT.
  • Cervical lymph node involvement is staged based on size and location (lateral cervical nodes: N1 ipsilateral ≤3 cm, N2a ipsilateral 3-6 cm, N2b ipsilateral >6 cm or bilateral, N2c bilateral or contralateral ≤6 cm) with metastatic nodes showing short-axis >1 cm and/or central necrosis.
  • MRI with dynamic contrast-enhanced sequences is superior for assessing soft tissue involvement and perineural spread, while CT excels at evaluating cortical bone involvement of the mandible or maxilla.
  • Associated findings may include ulceration, surface irregularity, and infiltration of surrounding musculature (tongue intrinsic muscles, mylohyoid, buccinator).
  • HPV-associated tumors may present in younger patients (<40 years) but are less common in oral cavity compared to oropharynx; they may show better prognosis than HPV-negative tumors.
Differential Diagnosis
  • Adenoid cystic carcinoma of minor salivary glands: typically smaller, well-defined lesions often in the hard palate with tendency for perineural spread; adenocarcinoma variants show different imaging characteristics than squamous cell carcinoma.
  • Lymphoma of oral cavity: usually presents as broader soft tissue infiltration with less surface ulceration; lacks the mucosal thickening pattern typical of squamous cell carcinoma.
  • Other salivary gland tumors (mucoepidermoid carcinoma): typically arises in parotid or submandibular glands rather than mucosal surfaces; location and glandular origin help distinguish.
  • Rhabdomyosarcoma: occurs in young children, shows more homogeneous appearance; clinical age and history distinguish from adult squamous cell carcinoma.
  • Infected ranula or odontogenic infection: may mimic tumor mass but typically shows cystic component, root pathology, or dental association not seen with carcinoma.
  • Radionecrosis of mandible with soft tissue changes: history of radiation, surrounding bone sclerosis/lysis pattern, and lack of clear mucosal primary lesion help differentiate from de novo squamous cell carcinoma.
Discussion

Alcohol and tobacco use remain the major risk factors for oral cavity squamous cell carcinoma, with cumulative exposure correlating with incidence and prognosis.

HPV infection is an emerging risk factor associated with increasing incidence in women younger than 40 years, though it remains less dominant than in oropharyngeal cancers.

Tumor size and local extension are the primary determinants of T-staging; bone invasion automatically assigns at least T4 status and significantly affects treatment approach (surgery vs. chemoradiation).

Cervical nodal staging is critical for prognosis and treatment: occult nodal disease is present in up to 30% of clinically N0 oral cavity cancers, making imaging surveillance essential.

Location-specific variants (tongue, floor of mouth, retromolar trigone) have different imaging appearance, drainage patterns, and prognosis that should be considered in reporting.

Imaging should assess not only primary tumor and nodal involvement but also resectability, proximity to critical structures (mandible, soft palate, retropharyngeal space), and potential for perineural spread.

Reporting Pearls

Report oral cavity squamous cell carcinoma by describing the exact anatomic site, maximal dimensions, T-stage based on size and adjacent structure involvement, presence/absence of bone invasion with specific cortical or marrow changes, and cervical nodal status with each node's size (short axis), location, and imaging characteristics (enhancement pattern, central necrosis, fatty hilum preservation) to guide staging and surgical planning.

Pitfalls
  • Mistaking normal anatomic variants (anterior tonsillar pillars, oral mucosa irregularities, dental artifacts) for mucosal thickening; compare with contralateral side and use multiplanar imaging to confirm pathology.
  • Underestimating mandibular invasion on MRI if cortical changes are subtle; always assess marrow signal, cortical interruption, and loss of fat planes—CT may be needed for equivocal cases.
  • Overlooking small but metastatic cervical lymph nodes that measure 8-10 mm short axis or show subtle necrosis; use size criteria and morphologic features (loss of fatty hilum) together rather than size alone.
  • Failing to systematically assess all high-risk subsites (anterior tongue, floor of mouth, lower lip) for multifocal disease or skip lesions, which may alter staging and treatment.